Cristin Peetoom, RPH | |
2022 E 16th St, Wellington, KS 67152-8151 | |
(620) 326-3321 | |
(620) 326-8012 |
Full Name | Cristin Peetoom |
---|---|
Gender | Female |
Speciality | Pharmacist |
Location | 2022 E 16th St, Wellington, Kansas |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1467824060 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | 1-12519 (Kansas) | Primary |
Mailing Address | Practice Location Address |
---|---|
Cristin Peetoom, RPH 2022 E 16th St, Wellington, KS 67152-8151 Ph: (620) 326-3321 | Cristin Peetoom, RPH 2022 E 16th St, Wellington, KS 67152-8151 Ph: (620) 326-3321 |
News Archive
Neuroscientists at McMaster University have found a link between children who are at risk for developmental coordination disorder (DCD), a common condition that can cause clumsiness, and difficulties with time perception such as interpreting changes in rhythmic beats.
National Journal: States are aware of the "lingering effects of recessions" on the enrollment in their Medicaid programs. "Because it takes time for people to re-enter the workforce and get insurance, it can take years for Medicaid rolls to shrink to prerecession levels and for states to restore program and funding cuts." According to a February report by the National Governors Association, states are "facing budget gaps totaling $136 billion for fiscal 2010 through 2012 and that Medicaid enrollment would grow 6.6 percent in fiscal 2010" (Werber Serafini, 3/13).
Severin Schwan thinks the skeptics are wrong. Those who shun the pharmaceutical sector for its lack of prospects don't understand the potential created by a rapidly growing understanding of genetics and molecular biology, and the new drugs that will follow. ... the chief executive of Roche Holding AG, the world's seventh-largest drug firm by sales, is an informed optimist.
In an editorial entitled "The Unmet Promise of a Miracle Drug for Alzheimer's Disease: Implications for Practice, Policy, and Research," Malaz Boustani, MD, MPH, a Regenstrief Institute research scientist and the founding director of the Indiana University Center for Health Innovation and Implementation Science, and co-authors Philip D. Sloane, MD, MPH and Sheryl Zimmerman, PhD, of the University of North Carolina at Chapel Hill, lament the unmet promise of a miracle drug for Alzheimer disease but are heartened by what they see as encouraging improvements in care for a growing population of older adults, many with dementia.
Using an approach combining in vivo recordings and optogenetic manipulations in mice, the researchers succeeded in showing that the inhibition of parvalbumin-expressing prefrontal interneurons triggers a chain reaction resulting in fear behaviour. Conversely, activation of these parvalbumin interneurons significantly reduces fear responses in rodents.
› Verified 1 days ago
Alice Ricke, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1111 W 8th St, Wellington, KS 67152 Phone: 620-326-5981 | |
Timothy James Mathes, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1111 W 8th St, Wellington, KS 67152 Phone: 620-326-5981 Fax: 620-326-4106 | |
Thomas Locker, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1111 W 8th St, Wellington, KS 67152 Phone: 620-326-5981 Fax: 620-326-4106 | |
Teri Will, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1111 W 8th St, Wellington, KS 67152 Phone: 620-326-5981 Fax: 620-326-4106 | |
Jeffrey Lee Janzen, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1111 W 8th St, Wellington, KS 67152 Phone: 620-326-5981 | |
Garry Wartick, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1111 W 8th St, Wellington, KS 67152 Phone: 620-326-5981 Fax: 620-326-4106 |